EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases

Harleen Kaur iD, Ramesh Bawaskar iD, Akash Khobragade, Dhiraj Kalra, Vedati Packiam, Mohammed Yamin Khan, Twinkle Kaur, Manish Sharma, Naval Kumar Verma, Subhash Kaushik, Anil Khurana

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0292783 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2023. Verfasst von Harleen Kaur und 10 weiteren Autor:innen. Beteiligte Einrichtung: Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, Janakpuri, New Delhi, India. Hauptthemen laut MEDLINE: COVID-19, Homeopathy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives No definite treatment is known for COVID-19 till date. The objective of this study is to assess the efficacy of customized Homoeopathic medicines, when used as an add-on treatment to Standard of Care (SOC), in patients suffering from moderate to severe COVID-19 infection.

Methods

This was a randomized, controlled, single-blind, parallel-group trial where 214 COVID19-positive patients were screened for moderate and severe cases of COVID-19. Adjuvant homoeopathic medicines were given in the treatment group and SOC was given to both groups. The duration of oxygen support was compared as the primary outcome. Subjects were followed for 28 days or till the end-point of mechanical ventilation/ death.

Results

Of 129 subjects included, 57 and 55 were severe; and 8 and 9 were moderate cases in Homoeopathy and SOC arms, respectively. In all, 9 (15.2%) participants in Homoeopathy and 20 (32.2%) participants in SOC arms eventually expired (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HomeopathyHumansSARS-CoV-2Single-Blind MethodBiomarkersOxygenTreatment Outcome

Substanzen

BiomarkersOxygen

Autor:innen und Institutionen

  • Central Council for Research in Homoeopathy, Ministry of AYUSH, Govt. of India, Janakpuri, New Delhi, India.
  • Regional Research Institute for Homoeopathy, Kharghar, Navi Mumbai, Maharashtra, India.
  • St. George's Hospital, Fort, Mumbai, Maharashtra, India.
  • Y.M.T. Dental College and Hospital, Kharghar, Navi Mumbai, Maharashtra, India.
  • Rejoice Health Foundation, New Delhi, India.

ORCID-Profile: Harleen Kaur, Ramesh Bawaskar

Zitieren

APA

Kaur, H., Bawaskar, R., Khobragade, A., Kalra, D., Packiam, V., Khan, M. Y., Kaur, T., Sharma, M., Verma, N. K., Kaushik, S., & Khurana, A. (2023). Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases. PLOS ONE. https://doi.org/10.1371/journal.pone.0292783

Vancouver

Kaur H, Bawaskar R, Khobragade A, Kalra D, Packiam V, Khan MY, et al. Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases. PLOS ONE. 2023. doi:10.1371/journal.pone.0292783

BibTeX
@article{Kaur2023,
  author = {Kaur, Harleen and Bawaskar, Ramesh and Khobragade, Akash and Kalra, Dhiraj and Packiam, Vedati and Khan, Mohammed Yamin and Kaur, Twinkle and Sharma, Manish and Verma, Naval Kumar and Kaushik, Subhash and Khurana, Anil},
  title = {Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0292783}
}
Kostenlos starten →